Jenburkt Pharmaceuticals Ltd Quarterly Result

Jenburkt Pharmaceuticals Ltd Quarterly Result

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

Net Profit - Last Quarter

₹ 10.85 Cr.

Last updated on: Jun 14, 2026

Jenburkt Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Jenburkt Pharmaceuticals Ltd for the Mar '26 is ₹ 48.98 crore as compare to the Dec '25 revenue of ₹ 44.84 crore.
  • This represent the growth of 9.23% The ebitda of Jenburkt Pharmaceuticals Ltd for the Mar '26 is ₹ 14.65 crore as compare to the Dec '25 ebitda of ₹ 9.24 crore.
  • This represent the growth of 58.55% The net profit of Jenburkt Pharmaceuticals Ltd for the Mar '26 is ₹ 10.85 crore as compare to the Dec '25 net profit of ₹ 5.93 crore.
  • This represent the growth of 82.97%.

Jenburkt Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Jun 20261187.45
11 Jun 20261157.65
10 Jun 20261178.2
09 Jun 20261163.2
08 Jun 20261159.7
05 Jun 20261137.7
04 Jun 20261123.5
03 Jun 20261127.15
02 Jun 20261141.55
01 Jun 20261159.4

Historical Revenue of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Jenburkt Pharmaceuticals Ltd News Hub

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November

Read more

29 Oct 24

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2

Read more

05 Nov 24

Jenburkt Pharmaceuticals to hold AGM

Jenburkt Pharmaceuticals announced that the 40th Annual General Meeting(AGM) of the company will be

Read more

21 May 25

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January

Read more

21 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Jenburkt Pharmaceuticals Ltd

  • Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
  • The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
  • It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
  • The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.

FAQs for Quarterly Results of Jenburkt Pharmaceuticals Ltd

What key financial metrics are included in Jenburkt Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Jenburkt Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Jenburkt Pharmaceuticals Ltd announce its quarterly results?

Jenburkt Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Jenburkt Pharmaceuticals Ltd's quarterly performance impact its stock price?

Jenburkt Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Jenburkt Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Jenburkt Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Jenburkt Pharmaceuticals Ltd's quarterly results?

Yes, Jenburkt Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions